Xin Huang

4PUBLICATIONS
14CO-AUTHORS
Medical infection agents (incl. prions)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 29, 2026
mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment.

|Oct 07, 2025
Sirp-α Antibody Inhibits Renal Cell Carcinoma Progression via Akt1/Akt2 Modulation in Tumor-Associated Macrophages.

Junfeng Hao, Naiquan Liu, Xin Huang

|Apr 06, 2023
Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway.

Junfeng Hao, Qiguang Chen, Yongmin Feng

|Feb 12, 2021
Prognostic Value of Soluble Suppression of Tumorigenicity 2 in Chronic Kidney Disease Patients: A Meta-Analysis.

Guangying Guo, Aoran Huang, Xin Huang

Pageof 1

Frequent Collaborators

2 joint publications

Junfeng Hao

1 joint publications

Guangying Guo

1 joint publications

Aoran Huang

1 joint publications

Tianhua Xu